Home
About us
Blog
Links and files
Gallery
English
New clinical endpoint for the measurement of treatment effectiveness in EPP
Pandemic isolation and EPP – A commentary
Important step towards a new causative treatment option for EPP
EPP patients spend an additional 6 hours per week outdoors when treated with afamelanotide
Overexposed – Documentary about EPP
The EMA recommends givosiran for AHP!
The Patient Perspective: A Matter of Minutes
The FDA approves givosiran for AHP!
MT-7117 ENDEAVOR Study for EPP
The FDA approves afamelanotide for EPP!
Posts navigation
1
2
Next Page
Home
About us
Blog
Links and files
Gallery
